How much caffeine is in Ecuador Typica Coffee?

Ecuador Typica Coffee contains approximately 1.41–1.42% caffeine by dry weight, placing it within the typical range for Coffea arabica cultivars, which generally fall between 0.9% and 1.7%. The exact milligrams per cup will vary based on brewing method, grind size, and water ratio, but this caffeine concentration is broadly comparable to other high-quality arabica coffees.

What makes Ecuador Typica Coffee different from other arabica varieties?

Ecuador Typica is a heritage landrace cultivar descended from the original Typica lineage introduced to South America in the early 18th century, adapted to Ecuador's specific altitude, soil, and climate conditions. Its documented fatty acid profile — notably cis-vaccenic acid and linoleic acid (9,12-octadecadienoic acid) — reflects cultivar and terroir-specific lipid composition, though no comparative phytochemical trials have formally quantified how it differs from other arabica cultivars in bioactive compound concentrations.

Are there any clinical studies on Ecuador Typica Coffee specifically?

No clinical trials or controlled human studies have been conducted on Ecuador Typica Coffee as a distinct cultivar as of the current research record. Any health claims for this variety must be extrapolated from the broader arabica coffee literature, which includes large epidemiological cohorts and some randomized trials, but cultivar-specific effects — especially regarding its unique fatty acid composition — remain entirely unstudied.

What are the fatty acids found in Ecuador Typica Coffee and do they have health effects?

Ecuador Typica Coffee contains cis-vaccenic acid (an omega-7 trans fatty acid of ruminant origin also found in some plant oils) and 9,12-octadecadienoic acid, commonly known as linoleic acid, an essential omega-6 polyunsaturated fatty acid. In broader nutritional research, linoleic acid supports membrane integrity and serves as a precursor to arachidonic acid and anti-inflammatory lipoxins, while cis-vaccenic acid has been associated with improved lipid profiles in some animal studies. However, no studies have assessed whether the concentrations of these fatty acids present in brewed Ecuador Typica Coffee are sufficient to produce measurable physiological effects in humans.

Is Ecuador Typica Coffee safe to drink every day?

For most healthy adults, daily consumption of Ecuador Typica Coffee is considered safe when total caffeine intake remains below 400 mg/day, consistent with guidance from the European Food Safety Authority (EFSA) and FDA. Individuals who are pregnant, have cardiovascular conditions, anxiety disorders, or are taking CYP1A2-sensitive medications such as clozapine or theophylline should consult a healthcare provider, as caffeine at this cultivar's concentration (1.41–1.42%) can interact with those pathways. No cultivar-specific safety concerns beyond those associated with standard arabica coffee have been identified.

How does the growing region affect Ecuador Typica Coffee's chemical composition?

Ecuador Typica Coffee's chemical profile, including its caffeine content (1.41-1.42%) and fatty acid composition, is influenced by the country's tropical altitude and volcanic soil conditions. The specific terroir of Ecuador produces distinctive phenolic compounds like 5-caffeoyl that may differ from the same cultivar grown in other regions. However, no comparative studies have directly measured how Ecuador's growing conditions affect the bioactive content compared to other origins of Typica coffee.

Can Ecuador Typica Coffee be used as a substitute for pharmaceutical caffeine supplements?

Ecuador Typica Coffee contains a consistent caffeine concentration of 1.41-1.42%, making it a natural caffeine source, though the amount per cup varies based on brewing method and serving size. Unlike standardized caffeine supplements, whole coffee also contains fatty acids and phenolic compounds whose combined effects on the body are not well-isolated in clinical research. For precise dosing needs, pharmaceutical caffeine supplements offer more controlled delivery than coffee, though Ecuador Typica provides caffeine within a food matrix that some prefer.

How does Ecuador Typica Coffee's fatty acid profile compare to other coffee cultivars?

Ecuador Typica Coffee contains cis-Vaccenic acid and 9,12-Octadecadienoic acid (linoleic acid), fatty acids also present in other arabica varieties, though the specific concentrations in this cultivar have not been directly compared in published research. These fatty acids are responsible for much of coffee's flavor and mouthfeel, and are generally considered part of the natural composition of whole coffee beans. No studies have established whether Ecuador Typica's particular fatty acid profile offers distinct health advantages over other arabica cultivars.

Ecuador Typica Coffee (Coffea arabica 'Ecuador Typica')

Ecuador Typica Coffee (Coffea arabica 'Ecuador Typica') is a heritage arabica cultivar grown in Ecuador containing approximately 1.41–1.42% caffeine by dry weight alongside notable fatty acids including cis-vaccenic acid and 9,12-octadecadienoic acid (linoleic acid). Its primary bioactive compound, caffeine, exerts stimulant effects by competitively antagonizing adenosine A1 and A2A receptors in the central nervous system.

Category: Coffee Cultivars Evidence: 2/10 Tier: Traditional

Ecuador Typica Coffee (Coffea arabica 'Ecuador Typica') — Hermetica Encyclopedia

Origin & History

Ecuador Typica Coffee is a cultivar variant of Coffea arabica L. originating from Ecuador's highland regions including Intag Valley and Manabí, where it grows at altitudes of 1000-1400 meters above sea level. This coffee variety produces beans with balanced structure and distinctive fruit-like flavors such as orange and pineapple, processed through standard roasting and brewing methods.

Historical & Cultural Context

No evidence of Ecuador Typica Coffee in traditional medicine systems was found in the available research. The cultivar is primarily discussed in modern contexts for sensory quality, cupping attributes, and commercial grading in Ecuadorian agriculture, without any documented historical medicinal use.

Health Benefits

• No specific health benefits documented - No clinical trials on Ecuador Typica Coffee were identified in the research
• Contains caffeine (1.41-1.42%) - General coffee research exists but no specific studies on this cultivar
• Rich in fatty acids including cis-Vaccenic acid and 9,12-Octadecadienoic acid - Chemical analysis only, no health outcome data
• Contains phenolic compounds like 5-caffeoylquinic acid - Composition data available but no clinical evidence
• Source of proteins (13.11-13.26%) and lipids (5.98-7.67%) - Nutritional content documented without health benefit studies

How It Works

Caffeine in Ecuador Typica Coffee acts as a non-selective adenosine receptor antagonist, blocking A1 and A2A receptors and thereby inhibiting cyclic AMP phosphodiesterase, which elevates intracellular cAMP and promotes norepinephrine and dopamine release. The linoleic acid (9,12-octadecadienoic acid) content may modulate inflammatory eicosanoid pathways via competitive incorporation into phospholipid membranes, reducing arachidonic acid availability for COX-mediated prostaglandin synthesis. Cis-vaccenic acid, an omega-7 fatty acid, has been associated in broader research with modulation of lipid metabolism and potential attenuation of hepatic lipogenesis, though no pathway studies exist specifically for this cultivar.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Ecuador Typica Coffee (Coffea arabica 'Ecuador Typica') were identified in the research. The available literature focuses exclusively on chemical composition, sensory profiles, and physical attributes rather than clinical outcomes, with no PubMed PMIDs provided for this specific cultivar.

Clinical Summary

No clinical trials have been conducted specifically on Ecuador Typica Coffee as a distinct cultivar, making it impossible to attribute quantified health outcomes directly to this variety. General Coffea arabica research — including large observational cohorts such as the EPIC study involving over 500,000 participants — associates regular coffee consumption with reduced risk of type 2 diabetes and liver disease, but these findings cannot be extrapolated exclusively to this cultivar. The caffeine content of 1.41–1.42% is consistent with typical arabica ranges, so caffeine-related cognitive and ergogenic findings from broader literature may apply, but cultivar-specific phytochemical differences have not been studied in controlled settings. Overall, the evidence base for Ecuador Typica Coffee specifically is absent; all health inferences rely on general arabica coffee research.

Nutritional Profile

Ecuador Typica Coffee (Coffea arabica 'Ecuador Typica') has been chemically characterized with the following known composition per available analytical data: Caffeine content: 1.41-1.42% (dry weight basis), placing it within the mid-range of Arabica cultivars. Fatty acid profile is documented and includes cis-Vaccenic acid (trans-11-octadecenoic acid, C18:1) and 9,12-Octadecadienoic acid (linoleic acid, C18:2n-6) as primary lipid components; total coffee oil content typical of Arabica ranges 15-17% of dry bean weight. Phenolic compounds include 5-caffeoylquinic acid (5-CQA, the predominant chlorogenic acid isomer in Arabica), with total chlorogenic acid content in Arabica species typically ranging 6-12% dry weight in green beans, though cultivar-specific quantification for Ecuador Typica is not precisely established beyond the 5-CQA identification. Protein content follows general Arabica parameters of approximately 10-13% dry weight (green bean), comprising free amino acids including glutamic acid, aspartic acid, and alanine which contribute to flavor development during roasting. Carbohydrates constitute approximately 38-42% dry weight in green beans, primarily sucrose (6-9%) and polysaccharides (arabinogalactans, mannans). Trigonelline (niacin precursor): approximately 0.6-1.2% dry weight, typical of Arabica. Mineral content follows general Arabica ranges: potassium (~1700 mg/100g dry), magnesium (~180 mg/100g dry), calcium (~120 mg/100g dry), phosphorus (~160 mg/100g dry). Bioavailability note: roasting significantly transforms composition — chlorogenic acids degrade 50-95%, trigonelline converts partially to niacin, and Maillard reaction products (melanoidins) form. No cultivar-specific bioavailability studies exist for Ecuador Typica.

Preparation & Dosage

No clinically studied dosage ranges for Ecuador Typica Coffee in extract, powder, or standardized forms are available, as no clinical studies have been conducted on this specific cultivar. Chemical analyses note typical caffeine content of 1.41-1.42% in related Arabica beans, but without standardization or dosing data tied to clinical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients studied, General Arabica coffee, Antioxidant supplements, B-vitamins, L-theanine

Safety & Interactions

Ecuador Typica Coffee contains caffeine at approximately 1.41–1.42%, and standard caffeine-related risks apply, including anxiety, insomnia, tachycardia, and elevated blood pressure at intakes above 400 mg/day in healthy adults. Caffeine inhibits adenosine activity and can interact with stimulant medications (e.g., ephedrine, amphetamines), anticoagulants like warfarin (via CYP1A2 competition), and certain antibiotics such as ciprofloxacin, which inhibit caffeine metabolism and can amplify side effects. Pregnant individuals are advised to limit total caffeine intake to under 200 mg/day (per WHO and ACOG guidelines) due to associations with low birth weight and preterm birth. Individuals with arrhythmias, anxiety disorders, GERD, or those sensitive to stimulants should exercise caution with any caffeinated coffee, including this cultivar.